Reversible posterior leukoencephalopathy syndrome in a patient with severe uremic encephalopathy

Clinical Nephrology

Volumn 74, Issue 2, 2010, Pages 154-158

  Tatsumoto, N ^a   Fujisaki, K ^a   Nagae, H ^a   Ono Fujisaki, A ^a   Kura Nakamura, N ^a   Taniguchi, M ^a   Masutani, K ^a   Tsuruya, K ^a   Iida, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Hemodialysis; Reversible posterior leukoencephalopathy syndrome; Uremic encephalopathy

Indexed keywords

ADULT; ARTICLE; BRAIN EDEMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; UREMIA; BRAIN DISEASES, METABOLIC; COMPLICATION; HYPERTENSIVE ENCEPHALOPATHY; MIDDLE AGED; PROCEDURES; RENAL REPLACEMENT THERAPY; SYNDROME;

BRAIN DISEASES, METABOLIC; BRAIN EDEMA; HUMANS; HYPERTENSIVE ENCEPHALOPATHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RENAL DIALYSIS; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; UREMIA;

EID: 77955733286     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp74154     Document Type: Article

References (30)

1. Akmal M, Goldstein DA, Multani S, Massry SG. Role of uremia, brain calcium and parathyroid hormone on changes in electroencephalogram in chronic renal failure. Am J Physiol. 1984; 246: 575-579.
2. Ay H, Buonanno FS, Schaefer PW, Le DA,Wang B, Gonzalez RG, Koroshetz WJ. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology. 1998; 51: 1369-1376. (Pubitemid 28520560)
3. Bakshi R, Bates VE, Mechtler LL, Kinkel PR, Kinkel WR. Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia. 1998; 39: 295-299. (Pubitemid 28141310)
4. Biasioli S, D'Andrea G, Feriaini M, Chiaramonte S, Fabris A, Ronco C, LaGreca G. Uremic encephalopathy: an updating. Clin Nephrol. 1986; 25: 57-63.
5. Biasioli S, D'Andrea G, Chiaramonte S, Fabris A, Feriaini M, Ronco C, Borin D, Brendolan A, La GrecaG. The role of neurotransmitters in the genesis of uremic encephalopathy. Int J Artif Organs. 1984; 7: 101-106. (Pubitemid 14097465)
6. Chen CL, Lai PH, Chou KJ, Lee PT, Chung HM, Fang HC. A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging. AJNR. 2007; 28: 68-71.
7. de Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, Haller H, Fliser D. Uremia causes endothelial progenitor cell deficiency. Kidney Int. 2004; 66: 641-646. (Pubitemid 38982006)
8. Donnan GA. Posterior leucoencephalopathy syndrome (commentary). Lancet. 1996; 347: 988.
9. Galons JP, Trouard T, Gmitro AF, Lien YH. Hemodialysis increases apparent diffusion coefficient of brain water in nephrectomized rats measured by isotropic diffusion-weighted magnetic resonance imaging. J Clin Invest. 1996; 98: 750-755. (Pubitemid 26349180)
10. Gottstein U, Held K, Sedlmeyer I, Steiner K, Haberlang KU, Berghoff W. Cerebral blood flow and cerebral metabolism in patients with chronic renal insufficiency. Klin Wochenschr. 1972; 50: 594-602.
11. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996; 334: 494-500.
12. Jeppsson B, Freund HR, Gimmon Z, James JH, von Meyenfeldt MF, Fischer JE. Blood-brain barrier derangement in uremic encephalopathy. Surgery. 1982; 92: 30-33.
13. Kevin NS, Gregory FW, Steven RM, Ronald LW, Scott EK. Dialysis disequilibrium: another reversible posterior leukoencephalopathy syndrome? Clin Neuro Neurosurg. 2003; 105: 249-252.
14. Komatsu Y, Shinghara A, Kukita C, Nose T, Maki Y. Reversible CT changes in uremic encephalopathy. Am J Neuroradiol. 1988; 9: 215-216.
15. Kupferschmidt H, Bont HA, Schnorf H, Landis T, Walter E, Peter J, Krahenbuhl S, Meier PJ. Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann InternMed. 1995; 123: 598-600.
16. Lanzino G, Cloft H, Hemstreet MK,West K, Alston S, Ishitani M. Reversible posterior leukoencephalopathy following organ transplantation description of two cases. Clin Neurol Neurosurg. 1997; 99: 222-226. (Pubitemid 27412449)
17. Mahoney CA, Arieff AI, Leach WJ, Lazarowitz VC. Central and peripheral nervous system effects of chronic renal failure. Kidney Int. 1983; 24: 170-177. (Pubitemid 13043146)
18. Moe SM, Spraque SM. Uremic encephalopathy. Clin Nephrol. 1994; 42: 251-256.
19. Ohta T, Sakano T, Siotsu M, Furue T, Ohtani H, Kinoshita Y, Mizoue T, Kiya K, Tanaka I. Reversible posterior leukoencephalopathy in a patient with Wegener's granulomatosis. Pediatr Nephrol. 2004; 19: 442-444. (Pubitemid 38477410)
20. Okada J, Yoshikawa K, Matsuo H, Kanno K, Oouchi M. Reversible MRI and CT findings in uremic encephalopathy. Neuroradiology. 1991; 33: 524-526.
21. Port JD, Beauchamp NJ Jr. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics. 1998; 18: 353-367.
22. Raroque HG, Orrison WW, Rosenberg G. Neurologic involvement in toxemia of pregnancy reversible MRI lesions. Neurology. 1990; 40: 167-169. (Pubitemid 20032917)
23. Schmidt M, Sitter T, Lederer SR, Held E. Reversible MRI changes in a patient with uremic encephalopathy. J Nephrol. 2001; 14: 424-427. (Pubitemid 33080988)
24. Schwartz RB, Jones KM, Klina P, Bajakian RL, Mantello MT, Garada B, Holman BL. Hypertensive encephalopathy findings on CT,MR imaging, and SPECTimaging in 14 cases.AmJ Roentgenol. 1992; 159: 379-383.
25. Soltes L, Schmalfuss IM, BhattiMT. Cortical blindness due to reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura and preeclampsia. Arch Ophthalmol. 2004; 122: 1885-1887.
26. TamCS, Galanos J, Seymour FJ, Pitman AG, Stark RJ, Prince HM. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol. 2004; 77: 72-76.
27. Tomson C. Cardiovascular disease in chronic renal failure. In: Feehally J, Floege J, Johnson R (eds). Comprehensive clinical nephrology. London: Mosby; 2007. p. 887-891.
28. Voltz R, Rosen FV, Yousry T, Beck J, Hohlfeld R. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin. Neurology. 1996; 46: 250-251. (Pubitemid 126425729)
29. Wennberg RA. Clinical and MRI evidence that occipital lobe seizures can be the major manifestation of the reversible posterior leukoencephalopathy syndrome (letter). Epilepsia. 1998; 39: 1381-1382.
30. Wijdicks EF. Neurotoxicity of immunosuppressive drugs. Liver Transpl. 2001; 7: 937-942.